🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

529 results for “Teva” Clear

  1. Pantoprazole Teva 40 mg maagsapresistente tabletten, Mycophenolate mofetil Sandoz 500 mg Film-coated Tablets, Mycophenolate Mofetil Accord 500 mg plėvele dengtos tabletės, CellCept 500 mg film-coated tablets

    Disc Medicine

    Post Transplantation Patients

    approved small molecule active

    1 trial
  2. Prednisolone 5mg Soluble Tablets, Certican 0,75 mg tablety, Mycofenolaat mofetil Sandoz 250 mg, capsules, hard, Envarsus 0.75 mg prolonged-release tablets, Simulect 20 mg powder and solvent for solution for injection or infusion, Ciclosporine Teva 25 mg, zachte capsules

    Disc Medicine

    kidney transplant

    approved small molecule active

    1 trial
  3. Qvar

    Teva Pharma GmbH

    Asthma

    approved small molecule terminated

    2 trials
  4. Qvar® (beclometasone dipropionate HFA)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial
  5. Rasagiline

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule active

    5 trials
  6. Rasagiline

    Teva Pharma GmbH

    Sleep Disturbances

    approved small molecule completed

    1 trial
  7. Rasagiline

    Teva Pharma GmbH

    Depressive Symptoms

    approved small molecule completed

    1 trial
  8. Rasagiline Mesylate

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    8 trials
  9. Rasagiline/Placebo

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    1 trial
  10. Reslizumab

    Teva Pharma GmbH

    Asthma

    approved small molecule active

    5 trials
  11. Reslizumab

    Teva Pharma GmbH

    Asthma; Eosinophilic

    approved mab completed

    1 trial
  12. SCE-B

    Teva Pharma GmbH

    Nocturnal Vasomotor Symptoms

    approved small molecule completed

    1 trial
  13. Shared Solutions® plus MS Center v. Shared Solutions®

    Teva Pharma GmbH

    Multiple Sclerosis

    approved other completed

    1 trial
  14. T-jet® containing TevTropin®

    Teva Pharma GmbH

    Growth Hormone Deficiency

    approved other completed

    1 trial
  15. armodafinil

    Teva Pharma GmbH

    Sleep Disorders

    approved small molecule completed

    1 trial
  16. diclofenac sodium topical gel

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    1 trial
  17. glatiramer acetate

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule active

    2 trials
  18. glatiramer acetate injection with oral cetirizine hydrochloride

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    1 trial
  19. mycophenolate mofetil (Myfenax)

    Teva Pharma GmbH

    Stable Renal Transplant Recipients

    approved small molecule terminated

    1 trial
  20. Albuterol eMDPI DS

    Teva Pharma GmbH

    Pulmonary Disease, Chronic Obstructive

    other completed

    1 trial
  21. Armodafinil

    Teva Pharma GmbH

    Sleep Apnea

    small molecule completed

    1 trial
  22. Azilect

    Teva Pharma GmbH

    Parkinson's Disease

    small molecule active

    1 trial
  23. Volcolon sugar free

    Teva Pharma GmbH

    Constipation

    small molecule completed

    1 trial
  24. extrafine HFA-beclomethasone

    Teva Pharma GmbH

    Asthma

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources